Key Takeaways
- EU member states will follow a common approach to confidentiality when sharing information through their national consultations carried out under the Health Technology Assessment Regulation.
- These consultations will determine each country’s needs relating to what should be reflected in the wider scoping process for EU-level joint clinical assessments (JCAs).
- The common approach should give developers of medicines and other health technologies some clarity and help member states put confidentiality agreements in place.
- Improved information sharing by developers is required to improve JCA resource planning.
EU member state authorities will adopt a common strategy to manage confidentiality when they conduct the national consultations necessary to prepare for the EU-level joint clinical assessments conducted under the...
The approach should bring more clarity for developers of drugs undergoing a JCA, said the Member State Coordination Group on HTA (HTACG), which coordinates the joint work carried out by...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?